Fig. 2.
Odds ratio (OR) for any bleeding complication in patients treated with ticagrelor versus clopidogrel (<1 favors ticagrelor). Crude and propensity score-adjusted OR and 95% confidence intervals are presented for the whole population, the subgroup undergoing percutaneous coronary intervention (PCI) ad hoc and the subgroup undergoing coronary angiography (CA) only.
